← Leaderboards
Alfred T Lane
Stanford University
$1,623,978
Attributed
$3,964,566
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $703.5K · FY2009–15$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,964,566 · 2
By mechanism
R01$3,510,882 · 1
P01$453,684 · 1
Top collaborators
- Paul A Khavari6 shared
- Matt Peter Marinkovich6 shared
Most similar at Stanford University
Same institution · by research overlap
- Paul A Khavari$40,653,927
- Matt Peter Marinkovich$8,061,995
- Mark A Kay$46,920,488
- Anthony E Oro$25,372,453
- Robert S Negrin$29,816,136
Others in their field
Top investigators on “Keratinocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Kathleen Janee Green · Northwestern University$26,824,381
- Elaine Fuchs · University Of Chicago$24,033,644
- Gian Paolo Dotto · Massachusetts General Hospital$19,822,465
- Richard L Gallo · University Of California, San Diego$19,668,478
- Pierre Coulombe · Johns Hopkins University$19,316,020
Research focus
KeratinocyteGene TherapyEpidermolysis BullosaEngineeringAnimal ModelBackCutaneousBasement MembraneBasic ScienceAchievementBullaCandidate IdentificationCaringCellsBaseCell TherapyCell TransplantsCessation Of LifeChildCicatrixClinicAutologousClinical TrialsAffect
Grant awards (8)
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$160,943
R01 · FY2015 · AR · contact PI
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$615,434
R01 · FY2013 · AR · contact PI
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$662,859
R01 · FY2012 · AR · contact PI
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$664,665
R01 · FY2011 · AR · contact PI
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$703,441
R01 · FY2010 · AR · contact PI
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa$703,540
R01 · FY2009 · AR · contact PI
CORE--PATIENT CARE$171,075
P01 · FY2001 · AR
CORE--PATIENT CARE$282,609
P01 · FY2000 · AR